Industry News

Cosmetic clinical trials must be planned with diversity as a priority

Oct 11, 2022, 06:17 AM by System

Medical research has a long, unfortunate track record of excluding ethnic and racial minority groups from clinical trials, a phenomenon that introduces remarkable uncertainty to the outcomes of taking medications or receiving laser-based medical treatments in these populations. Similarly, chronic medical conditions and adverse reactions to treatment that disproportionately affect minority groups, such as people of color, have historically garnered less investigative attention than those that affect majority groups. This has led to increased morbidity and mortality in minority groups.

The U.S. Census Bureau projects that people with skin of color will constitute 50.3% of the U.S. population by 2045, up from 39.7% in 2019. As this...
Load more comments
Comment by from